Research Laboratories

  • The Genetics Laboratory provides specialist facilities for DNA and RNA research and the analysis of the molecular mechanisms underlying physiological and disease processes. 

    Its equipment includes an Auto-Pure Mini automated nucleic acid extraction system, a Real-Time PCR (qPCR) thermal cycler, a microvolume spectrophotometer for assessing DNA/RNA concentration and purity, agarose gel electrophoresis systems, a laminar flow cabinet, refrigerated centrifuges with rotors for tubes and PCR plates, and facilities for storing material at −80°C. 

    The infrastructure enables the entire molecular analysis workflow: from standardised DNA/RNA extraction and purification, through material quality control, to amplification and quantitative gene expression analysis, as well as verification of PCR products by electrophoresis. Automated sample preparation increases assay reproducibility and reduces the risk of contamination and manual errors. 

    Main research areas:

    • Profiling mRNA and miRNA expression and assessing changes in gene expression in response to ischaemia, hypoxia, oxidative stress, therapeutic substances and other interventions; 
    • Identifying molecular biomarkers of disease and potential therapeutic targets; 
    • Analysing polymorphisms and selected genetic alterations in the context of disease predisposition and pharmacogenomics; 
    • Assessing genotoxicity, DNA integrity and cellular molecular responses to environmental factors and xenobiotics; 
    • Analysing the expression of markers of apoptosis, proliferation, inflammation and angiogenesis; 
    • Molecular detection of pathogens and monitoring the purity of biological material, including PCR detection of Mycoplasma spp. 

    Research being conducted:

    • miRNAs as modern biomarkers and potential therapeutic targets in acute and chronic brain diseases - the laboratory enables RNA extraction, assessment of its quality and quantitative profiling of selected miRNAs using RT-qPCR; 
    • Antisense oligonucleotides as a potential therapeutic tool in acute and chronic brain diseases - the molecular research facilities can be used to assess changes in the expression of target transcripts.